Rassi H, Houshmand M, Hashemi M, Majidzadeh K, Akbari M H Hosseini, Panahi M Shafa Shariat
National Medical Academy, Kiev, Ukraine.
Tsitol Genet. 2008 Mar-Apr;42(2):55-62.
Breast cancer is the most common malignancy among females in the world. Age and familial history are the major risk factors for the development of this disease in Iran. Mutations of BRCA1 and BRCA2 genes are associated with a greatly increased risk for development of familial breast cancer. Frequency of BRCA mutations was identified in familial breast cancers (FBC) and non-familial breast cancers (NFBC) by molecular genetics, morphological and Immunohistochemical methods. Thirty forth formalin-fixed, paraffin-embedded breast tissue tumors were analyzed from 16 patients with FBC and 18 patients with NFBC. Three 5382insC mutations detected by multiplex PCR in 16 familial breast cancers. Immunohistochemical method was used to detect estrogen receptor (ER) and progesterona receptor (PR) and TP53. Comparison of ER, PR and TP53 exhibited high difference (P < 0.0001) in familial breast cancers and non-familial breast cancers. Our results demonstrated that 5382insC mutation, ER, PR, TP53, mitotic activity, polymorphism, necrosis and tubules can serve as the major risk factors for the development of FBC.
乳腺癌是全球女性中最常见的恶性肿瘤。年龄和家族史是伊朗该疾病发生的主要危险因素。BRCA1和BRCA2基因的突变与家族性乳腺癌发生风险的大幅增加相关。通过分子遗传学、形态学和免疫组织化学方法,在家族性乳腺癌(FBC)和非家族性乳腺癌(NFBC)中确定BRCA突变的频率。对16例FBC患者和18例NFBC患者的34个福尔马林固定、石蜡包埋的乳腺组织肿瘤进行了分析。通过多重PCR在16例家族性乳腺癌中检测到3个5382insC突变。采用免疫组织化学方法检测雌激素受体(ER)、孕激素受体(PR)和TP53。ER、PR和TP53在家族性乳腺癌和非家族性乳腺癌中的比较显示出高度差异(P < 0.0001)。我们的结果表明,5382insC突变、ER、PR、TP53、有丝分裂活性、多态性、坏死和小管可作为FBC发生的主要危险因素。